Delivery Order SPE2DX22D0010-SPE2D826FCW83
- Not listed
- Amerisourcebergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order contract valued at $11,659.64 by the Defense Logistics Agency Medical Supply Chain on February 2, 2026. This firm fixed-price, non-set-aside contract has an ultimate completion date of February 3, 2026 and represents a child contract under the parent entity Cencora, Inc. (doing business as Amerisourcebergen). The delivery order falls under...
- Amerisourcebergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $650,959.80 by the Defense Logistics Agency's Medical Supply Chain on February 2, 2026, with an ultimate completion date of February 3, 2026. This competitively awarded, firm fixed-price contract carries no set-aside designation and represents a task order under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical valued...
- Amerisourcebergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,287.20 on January 6, 2026, by the Defense Logistics Agency's Medical Supply Chain with an ultimate completion date of January 7, 2026. This competitively awarded, firm fixed-price contract represents a child award under Amerisourcebergen's parent company Cencora, Inc. and carries no set-aside designation. The delivery order falls under...
- Amerisourcebergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $40,566.20 by the Defense Logistics Agency's Medical Supply Chain on January 13, 2026. This firm fixed-price delivery order, which concludes on January 14, 2026, represents a competitively awarded contract with no set-aside designation. The award leverages Amerisourcebergen's established relationship with the federal government as a critical...
- Amerisourcebergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,127.28 on January 29, 2026, by the Defense Logistics Agency's Medical Supply Chain. The contract is classified as a firm fixed-price delivery order with an ultimate completion date of January 30, 2026, and utilizes no set-aside designation, indicating it was competitively awarded. This delivery order represents a task order issued under...
- Amerisourcebergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $3,586.60 by the Department of Defense Medical Supply Chain on January 12, 2026, with an ultimate completion date of January 13, 2026. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation. The award represents a task order under Amerisourcebergen's parent company Cencora, Inc.'s larger Indefinite Delivery...
- Amerisourcebergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $64,044.00 by the Defense Logistics Agency (DLA) Medical Supply Chain on January 12, 2026, with an ultimate completion date of January 13, 2026. This firm fixed-price delivery order represents a non-set-aside, competitively awarded contract and is issued under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support...
- Amerisourcebergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $11,122.80 by the Defense Logistics Agency Medical Supply Chain on January 8, 2026, with an ultimate completion date of January 9, 2026. This firm fixed-price, non-set-aside contract represents a child order under Amerisourcebergen's parent organization Cencora, Inc. (doing business as Amerisourcebergen). The award is issued under Cencora's larger...
- Amerisourcebergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $54,536.55 on January 22, 2026, by the Defense Logistics Agency's Medical Supply Chain. This firm fixed-price delivery order, with an ultimate completion date of January 23, 2026, was competitively awarded with no set-aside designation. The award is structured as a child contract under Cencora, Inc. (Amerisourcebergen's parent company), leveraging...
- Amerisourcebergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,845.62 by the Defense Logistics Agency's Medical Supply Chain on January 30, 2026, with an ultimate completion date of February 2, 2026. This firm fixed-price contract represents a competitively awarded, non-set-aside procurement and is issued under Amerisourcebergen's parent company, Cencora, Inc. (doing business as Amerisourcebergen), which...
- SPE2DX22D0010Indefinite Delivery Contract
- SPE2DX22D0010-SPE2D826FCW83Delivery Order
Amerisourcebergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $6,040.44 by the Defense Logistics Agency's Medical Supply Chain on February 2, 2026, with an ultimate completion date of February 3, 2026. This firm fixed-price, non-set-aside contract is a child order under Amerisourcebergen's parent company Cencora, Inc., which holds a substantial Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999.00 through December 2031. The delivery order represents a routine pharmaceutical supply transaction executed under this comprehensive global pharmaceutical support vehicle, which enables the company to supply military healthcare systems with an extensive range of medications and medical commodities. The award reflects Amerisourcebergen's established role as a critical federal medical procurement vendor for military and veteran healthcare systems. The company has demonstrated consistent capability to fulfill competitive federal pharmaceutical requirements across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, vaccines, and medical supplies. This delivery order exemplifies the operational efficiency of the DLA's pharmaceutical prime vendor model, which leverages long-term indefinite delivery contracts to streamline the procurement and distribution of essential medical products to support military treatment facilities and federal healthcare operations worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.0k | 2/1/26 |